Inverness Medical to Climb Self-Testing Mountain With a Heap of Scottish Cash | GenomeWeb

Can Scottish support help Inverness Medical Innovations beat the odds on at-home diagnostics?

The Waltham, Mass. diagnostic and nutritional supplement company will receive $57 million from Scottish government-funded ITI Life Sciences to develop a new diagnostic platform for use in human-health tests. The company also plans to spend $129 million of its own money to research, develop, manufacture, and commercialize the tests, with an initial focus on near-patient and in-home cardiology diagnostics, Inverness said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.